Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600116001) titled 'Clinical Guiding Value of Targeted Sequencing of Blood Microorganisms in Febrile Patients with Malignant Tumors' on Jan. 4.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Cancer Hospital, Chinese Academy of Medical Sciences
Condition:
Cancer
Intervention:
Retrospective case analysis of patients with malignant tumors and fever detected by conventional methods.:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-11-29
Target Sample Size: Retrospective case analysis of patients with malignant tumors and fever detected by conventional methods.:60...